menu
    • menu
    [{"orgOrder":0,"company":"Fathom Pharma","sponsor":"Consegna Pharma","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"Consegna Pharma Acquires Fathom Pharma to Strengthen Initiatives that Address the Opioid Crisis","therapeuticArea":"Neurology","highestDevelopmentStatus":"Undisclosed","country":"","productType":"Small molecule","productStatus":"New Molecular Entity","date":"April 2022","year":"2022","type":"Acquisition","leadProduct":"FP01","moa":"","url1":"","url2":"","graph1":"Neurology","graph2":"Undisclosed","graph3":"Fathom Pharma","amount2":0,"therapeuticAreaNew":"Neurology","highestDevelopmentStatusNew":"Undisclosed","highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Neurology","productSubType":"","amount2New":0,"dosageForm":"Injection","sponsorNew":"Fathom Pharma \/ Consegna Pharma","highestDevelopmentStatusID":"1","companyTruncated":"Fathom Pha.."}]

    Find Clinical Drug Pipeline Developments & Deals by Fathom Pharma

    Menu

    Fathom Pharma

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Fathom Pharma

                            U.S.A arrow
                            Formnext Forum
                            Not Confirmed

                            Fathom Pharma

                            U.S.A arrow
                            Formnext Forum
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : FP01

                            Therapeutic Area : Neurology

                            Study Phase : Undisclosed

                            Sponsor : Consegna Pharma

                            Deal Size : Undisclosed

                            Deal Type : Acquisition

                            DEALS_DEV arrow-down

                            Consegna Pharma Acquires Fathom Pharma to Strengthen Initiatives that Address the Opioid Crisis

                            Details : Fathom joining Consegna, will accelerate the clinical development of combined LAI (long-acting injectables) focused on several aspects of pain signaling pathways. Fathom Pharma develops new treatments for chronic pain that includes FP01, as a treatment ...

                            Brand Name : FP01

                            Molecule Type : Small molecule

                            Upfront Cash : Undisclosed

                            April 19, 2022

                            Lead Product(s) : FP01

                            Therapeutic Area : Neurology

                            Highest Development Status : Undisclosed

                            Sponsor : Consegna Pharma

                            Deal Size : Undisclosed

                            Deal Type : Acquisition

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth